These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The creation of therapeutic orphans--or, what have we learnt from the Debendox fiasco? Sheffield LJ; Batagol R Med J Aust; 1985 Aug; 143(4):143-7. PubMed ID: 3927122 [TBL] [Abstract][Full Text] [Related]
63. Debendox in early pregnancy and fetal malformation. Fleming DM; Knox JD; Crombie DL Br Med J (Clin Res Ed); 1981 Jul; 283(6284):99-101. PubMed ID: 6789952 [TBL] [Abstract][Full Text] [Related]
64. Fetal malformation after Debendox treatment in early pregnancy. Br Med J; 1978 Apr; 1(6119):1055-6. PubMed ID: 638604 [No Abstract] [Full Text] [Related]
65. Bendectin and human congenital malformations. Shiono PH; Klebanoff MA Teratology; 1989 Aug; 40(2):151-5. PubMed ID: 2772850 [TBL] [Abstract][Full Text] [Related]
66. Drugs and stillbirth. Porter JB; Hunter-Mitchell J; Jick H; Walker AM Am J Public Health; 1986 Dec; 76(12):1428-31. PubMed ID: 3777291 [TBL] [Abstract][Full Text] [Related]
69. Bendectin and birth defects: hopefully, the final chapter. Brent R Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):79-87. PubMed ID: 12769503 [No Abstract] [Full Text] [Related]
70. Study of prescription drugs in the first trimester and congenital malformations. McBride WG Aust N Z J Obstet Gynaecol; 1993 May; 33(2):220. PubMed ID: 8216137 [No Abstract] [Full Text] [Related]
72. Indications for bendectin narrowed. FDA Drug Bull; 1981 Mar; 11(1):1-3. PubMed ID: 7215728 [No Abstract] [Full Text] [Related]
73. First-trimester drug use and congenital disorders. Aselton P; Jick H; Milunsky A; Hunter JR; Stergachis A Obstet Gynecol; 1985 Apr; 65(4):451-5. PubMed ID: 3982720 [TBL] [Abstract][Full Text] [Related]
74. Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis. Mitchell AA; Schwingl PJ; Rosenberg L; Louik C; Shapiro S Am J Obstet Gynecol; 1983 Dec; 147(7):737-42. PubMed ID: 6650593 [TBL] [Abstract][Full Text] [Related]
75. Debendox and pregnancy. Med J Aust; 1984 Oct; 141(8):546-7. PubMed ID: 6482805 [No Abstract] [Full Text] [Related]
76. Science v. law. A decade-old rule on scientific evidence comes under fire. Brickley P Sci Am; 2003 Dec; 289(6):30-2. PubMed ID: 14631724 [No Abstract] [Full Text] [Related]
77. The value of case reports in human teratology. Goldberg JD; Golbus MS Am J Obstet Gynecol; 1986 Mar; 154(3):479-82. PubMed ID: 3456709 [TBL] [Abstract][Full Text] [Related]
78. Congenital malformations (second of two parts). Kalter H; Warkany J N Engl J Med; 1983 Mar; 308(9):491-7. PubMed ID: 6337336 [No Abstract] [Full Text] [Related]
79. Response to Dr. Stuart Newman's commentary on an article entitled "Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen". Brent RL Reprod Toxicol; 1999; 13(4):245-53. PubMed ID: 10453909 [No Abstract] [Full Text] [Related]
80. Bendectin (Debendox) as a risk factor for pyloric stenosis. Eskenazi B; Bracken MB Am J Obstet Gynecol; 1982 Dec; 144(8):919-24. PubMed ID: 7148924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]